Member Info for PlantPower

https://uk.reuters.com/article/uk-health-coronavirus-britain-phe/public-health-england-to-be-scrapped-and-replaced-by-new-body-telegraph-idUKKCN25B0ZD

Hi hillybilly - always a pleasure seeing u pop in, now off u trot.

Peace&Plants

In hindsight this article appears to be spot on by Proactive Investors on 21st July (quoting FT):

https://www.proactiveinvestors.co.uk/companies/amp/news/924736?__twitter_impression=true

“Laboratory operators in the US have said a lack of capacity has created a backlog of tests that are being processed too slowly to stem the tide of infections
Genedrive PLC - Coronavirus test makers could be about to cash in as US heads for winter crunch

A number of London-listed groups making coronavirus tests could potentially be in line to benefit from a coming shortage of US testing capacity.

In a Financial Times report on Tuesday, executive vice-president of US lab operator Quest Diagnostics James Davis warned that it will be impossible to increase testing rates to cope with demand during autumn when cases of seasonal flu and common colds appear presenting similar symptoms to coronavirus.

Testing companies are finding themselves struggling to keep up with capacity as the pandemic ravages the US, with no signs that the infection rate will slow in the next few months.

Davis said the there was “no way” testing capacity will be doubled in the next three months, highlighting a shortage of chemical reagents and testing machines from manufacturers.

The backlog also means the current official figures for US infections, around 3.9mln cases at the last count, is likely to be out of date alongside the death figure of around 143,000.

Davis told the FT that “other solutions need to be found” to clear the logjam, other testing would cease to serve a purpose due to the delays making containment and tracing nearly impossible.

Possible opportunity

With laboratory testing in the US buckling under the weight of its coronavirus caseload, there could be a possible opening for firms developing rapid tests that do not require laboratory analysis to target the shortage in the American market as winter approaches.

Potential beneficiaries include Genedrive PLC (LON:GDR), which is currently awaiting approval by regulators for its point of care Genedrive 96 SARS-CoV-2 test, which has already received over £1mln indicative orders and is targeted for release at the end of 2020......”

I would think so too to a degree, as expect FTSE has more pain to come, although GDR still far too speculative at this stage to suit many, as soon approvals / orders are in play, then we’ll see an influx....

I think post summer / 2nd wave (unfortunately) / main markets suffering / Covid stocks in play approval wise & with order book to boot, will do very well.

Bud seems to be lining up the strategic plays with sticky & huge contracts with the big boys - frustrating wait for many, but this is innovative diagnostic product launch in unchartered waters with dependency on multiple external medical regulatory bodies , so can see how it takes time.

Will look to post another updated SWOT over the wkd, it’s been a while....all, any thoughts to add, let me know, will repost last SWOT shortly.

PP

13k vol trade @ 94.65p, time stamp 15.43 still there

Day vol:

Buy: 370,101
Sell: 374,628
Delayed: 26,682

Expect lots of buys printed as sells as SP flew north earlier.

PP

Totally agree - we know it’s proverbial ‘December’ and Xmas day must be soon but just not sure when....

The good news is, in my opinion, is fear has gone - it’s just a question of ‘when’, rather than ‘if’.....

Looking forward to Genedrive’s and our well deserved day(s) in the sun.

PP

Delayed trades will be interesting

I think i matched you on the buybacks - hey ho, really think it will not matter over next few weeks or so.

Seems 92p finish - next week will be fun I think.

PP

94.4p paid though..

Ah....slipping to 92.5p....let’s see...

PP

@bigAl - nicely timed top up this week ;0)

Afternoon all - still think circa 95p close will be a great platform for next week.

I think our much needed friend ‘momentum’ is back onboard the BudExpress paying full fare.....

Toot, Toot.

#PeacePlantsPatience...Prosper

I’d take finish at this SP

(Repost)...we’re making the right strategic moves to be a big player in the Covid testing market for the foreseeable future.

Right scaleable product
Right global strategic manufacturing partnerships
Right global strategic scaleable automated throughout partner
Right strategically targeted geographical areas
Right strategic distribution partners (more to come)
Right strategic forward looking CEO
Right strategic investment backing (GHIF)
Right strategic scaleable platform / product extension (POC)
Right sticky long term shareholders ;0)

Yesterday’s and today’s movement great setup for next week - let’s see how much this holds going into the wkd.

The right news will propel GDR back to levels that’ll bring smiles back to most LTHs.

This only the hors d'oeuvre....

PP

Roll up, roll up, Last chance, all aboard the BudExpress...ready for £1+

PP

That mystery seller! Await TRS to confirm...

98.99p paid.....ohhhh

95.96p paid...

94p paid..